Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,431 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $256.47 | 2 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $241.07 | 3 | $0 (2020) |
| SK Life Science, Inc. | $125.00 | 1 | $0 (2021) |
| Novo Nordisk Inc | $124.59 | 1 | $0 (2018) |
| GENZYME CORPORATION | $122.04 | 1 | $0 (2021) |
| Amgen Inc. | $121.83 | 1 | $0 (2020) |
| GlaxoSmithKline, LLC. | $121.34 | 1 | $0 (2018) |
| TESARO, Inc. | $121.12 | 1 | $0 (2018) |
| ACADIA Pharmaceuticals Inc | $102.92 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $94.16 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $372.04 | 3 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2020 | $241.83 | 2 | Amgen Inc. ($121.83) |
| 2018 | $488.12 | 5 | Novo Nordisk Inc ($124.59) |
| 2017 | $328.55 | 3 | AstraZeneca Pharmaceuticals LP ($131.47) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/01/2021 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 09/16/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/29/2021 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $122.04 | General |
| 03/11/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Central Nervous System | ||||||
| 01/27/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Cardiology | ||||||
| 10/30/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.59 | General |
| Category: Diabetes | ||||||
| 06/30/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $121.34 | General |
| Category: RESPIRATORY | ||||||
| 05/01/2018 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $121.12 | General |
| Category: ONCOLOGY | ||||||
| 04/09/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: Central Nervous System | ||||||
| 03/31/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $114.58 | General |
| Category: Central Nervous System | ||||||
| 08/30/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $94.16 | General |
| Category: DIABETES | ||||||
| 08/24/2017 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $131.47 | General |
| Category: Oncology | ||||||
| 08/16/2017 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $102.92 | General |
| Category: PDP | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 103 | 681 | $89,965 | $66,566 |
| 2022 | 4 | 168 | 997 | $127,130 | $83,869 |
| 2021 | 3 | 106 | 627 | $79,720 | $53,759 |
| 2020 | 3 | 197 | 728 | $92,320 | $63,022 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 51 | 605 | $75,325 | $57,284 | 76.0% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 40 | 43 | $11,290 | $7,046 | 62.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 12 | 33 | $3,350 | $2,237 | 66.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 71 | 846 | $101,480 | $68,457 | 67.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 55 | 66 | $16,500 | $9,707 | 58.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 29 | 72 | $7,200 | $4,495 | 62.4% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 13 | 13 | $1,950 | $1,210 | 62.1% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 43 | 536 | $64,320 | $44,343 | 68.9% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 39 | 42 | $10,500 | $6,324 | 60.2% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 24 | 49 | $4,900 | $3,092 | 63.1% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 124 | 616 | $73,920 | $51,681 | 69.9% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2020 | 43 | 48 | $12,000 | $7,262 | 60.5% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 30 | 64 | $6,400 | $4,078 | 63.7% |
About Dr. James Chen, M.D
Dr. James Chen, M.D is a Internal Medicine healthcare provider based in Belmont, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164531141.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Chen, M.D has received a total of $1,431 in payments from pharmaceutical and medical device companies, with $372.04 received in 2021. These payments were reported across 13 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,431).
As a Medicare-enrolled provider, Chen has provided services to 574 Medicare beneficiaries, totaling 3,033 services with total Medicare billing of $267,215. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Belmont, CA
- Active Since 08/30/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164531141
Products in Payments
- IMFINZI (Drug) $131.47
- LOKELMA (Drug) $125.00
- XCOPRI (Drug) $125.00
- Ozempic (Drug) $124.59
- Repatha (Biological) $121.83
- NUCALA (Biological) $121.34
- ZEJULA (Drug) $121.12
- AUSTEDO (Drug) $121.07
- AJOVY (Biological) $120.00
- NUPLAZID (Drug) $102.92
- TOUJEO (Drug) $94.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Belmont
Adam Shaywitz, Md Phd, MD PHD
Internal Medicine — Payments: $4,800
Dr. Jesse Waggoner, M.d, M.D
Internal Medicine — Payments: $3,586
Dennis Hughes, M.d, M.D
Internal Medicine — Payments: $668.76
Dr. Tracei Ball, Md, MD
Internal Medicine — Payments: $536.38
Dr. Rahel Bosson, M.d, M.D
Internal Medicine — Payments: $214.11
Dr. Marie President, M.d, M.D
Internal Medicine — Payments: $195.14